Rottapharm S.p.A. researches, develops, manufactures, markets, and distributes consumer healthcare products, reimbursed prescription products, and natural extracts in Italy and internationally. It offers various pharmaceutical products in the areas of cardiology, gastroenterology, gynecology, pediatrics, respiratory system, rheumatology, and urology; personal care products in the areas of gynecology, pediatrics, dermatology, sun protection, hair care, and others; and nutraceuticals in the areas of gynecology, cardiology, rheumatology, and dermatology. The company was founded in 1961 and is headquartered in Monza, Italy. As of October 10, 2014, Rottapharm S.p.A. operates as a subsidiary of Me...
Via Valosa di Sopra, 9
Monza, MI 20900
Founded in 1961
Meda AB, Rottapharm S.p.A. - M&A Call
Jul 31 14
To discuss the acquisition of Rottapharm¦Madaus by Meda
Rottapharm SpA Announces Earnings Results for the First Quarter of 2014
May 19 14
Rottapharm SpA announced earnings results for the first quarter of 2014. For the quarter, the company booked a net profit of EUR 2.1 million, compared with a net loss of EUR 3.3 million for the same period last year. Consolidated revenues grew 15.4% annually to EUR 116.6 million, driven by higher sales in Italy which accounted for 29% of all. Adjusted earnings before interest, tax, depreciation and amortization soared 106% to EUR 18.5 million
and adjusted earnings before interest and tax surged 218% to EUR 12.7 million.